MARKET

BIO-B

BIO-B

Bio Rad Laborato
NYSE

Real-time Quotes | Nasdaq Last Sale

520.15
+15.15
+3.00%
Closed 16:00 05/27 EDT
OPEN
--
PREV CLOSE
505.00
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
826.65
52 WEEK LOW
482.87
MARKET CAP
15.57B
P/E (TTM)
-106.6887
1D
5D
1M
3M
1Y
5Y
BRIEF-Bio-Rad Reports First-Quarter 2022 Financial Results
reuters.com · 04/28 22:19
BRIEF-Bio-Rad Reports Fourth-Quarter And Full-Year 2021 Financial Results
reuters.com · 02/10 21:56
LIVE MARKETS-All it took was a few minutes, and the market tanked
reuters.com · 01/05 21:26
LIVE MARKETS-2022: Another positive year for stocks, but not without some indigestion
reuters.com · 01/05 19:19
LIVE MARKETS-Biggest Q4 profit gains seen in energy, materials, industrials
reuters.com · 01/05 18:29
LIVE MARKETS-2021 saw a lot less volatility in the S&P 500
LIVE MARKETS-2021 saw a lot less volatility in the S&P 500
reuters.com · 01/05 17:43
LIVE MARKETS-US Treasury yields face technical resistance after big jump
reuters.com · 01/05 17:27
LIVE MARKETS-Europe: no 2022 dip to buy yet!
reuters.com · 01/05 17:00
More
No Data
Learn about the latest financial forecast of BIO-B. Analyze the recent business situations of Bio Rad Laborato through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.86%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Chairman/President/Chief Executive Officer/Director
Norman Schwartz
Chief Financial Officer/Executive Vice President
Ilan Daskal
Chief Operating Officer/Executive Vice President
Andrew Last
Executive Vice President/General Counsel/Secretary
Timothy Ernst
Executive Vice President
Michael Crowley
Executive Vice President
Simon May
Executive Vice President
Dara Wright
Lead Director/Independent Director
Gregory Hinckley
Independent Director
Jeffrey Edwards
Independent Director
Melinda Litherland
Independent Director
Arnold Pinkston
No Data
No Data
About BIO-B
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.

Webull offers kinds of Bio-Rad Laboratories, Inc. stock information, including NYSE:BIO B real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO B stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIO-B stock methods without spending real money on the virtual paper trading platform.